In any case, the enhanced expression of total tau, NRGN and REST in plasma NDEVs from advanced AD cases is not due to severity-related variations in CD81 + NDEV counts, and needs to be replicated and further investigated. The gene discussed is MAPT; the disease is Alzheimer disease.